pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1303 |
Genomic Coordinates | chr5: 154685776 - 154685861 |
Synonyms | MIRN1303, hsa-mir-1303, MIR1303 |
Description | Homo sapiens miR-1303 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1303 | ||||||||||||||||||||||||||||||||||||||||||
Sequence | 52| UUUAGAGACGGGGUCUUGCUCU |73 | ||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ZYG11B | ||||||||||||||||||||
Synonyms | ZYG11 | ||||||||||||||||||||
Description | zyg-11 family member B, cell cycle regulator | ||||||||||||||||||||
Transcript | NM_024646 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ZYG11B | |||||||||||||||||||||
3'UTR of ZYG11B (miRNA target sites are highlighted) |
>ZYG11B|NM_024646|3'UTR 1 TAGCCATAAGTATTGGATAGTTGAATCACAGGAATCCTTTTTGTGATTGGTCCATTTGGAATATCTTACCCTCCCTGATG 81 TTTTGGGGGTTTCTATGACAAGAGTCATAAAATCAGTTTGGGATTGATAATGTGTAGTACTGCCCATGTGAACAGTCTCT 161 AATTTGTCTTGTGATTTTAAACTTATGAGTCAAGAAGGGTCTCTTCCTTTATCATTGCCTTTTAGGAAATTTTCCACATC 241 TTTCAGTGTTTGAACTTACTTGTGCTTGAGATTCTACAGTTTTATGGTAAAGTTTGCACGAACCCTTAGGCCAGACTTTT 321 CTGATCTCAGAGTCCCTTCCAATCAATTTGCAGCTTCACATAAGCTGTTGACCTGATTTCTGACACTGCTTCAGTTGTAA 401 ATTTTATACTGCTTCTGTATAAAATGCCTTTCTTCTCTATCTGTGTATATTTTATAAGATGTCCTTCTTAGTGTGAAAGA 481 AGGGAAATGTGGATCATCTTGTGGAAGCTAATCACTGGCAGGAGCCTGGATGGCTGGCGGAAAGATATATGAGAAAGAAA 561 AATTATGAAGGTAGAACAGAGTGTAGGAACTGGGAATTGGTTTCATGGTATAGGTTTTAAAATGAGACAGGCTACCCTTC 641 GGGAGTCCACCTCTCTTGAGGCGGTGAGCAGAAGCTTGTCCTCCATATTTATACCTAGAAGTGTGGACTGCTGGTTCCTG 721 CACAGACTGCCGGTTATTCACTAGGAATATTTCCCCAAGCACCACAGTATAAAATACTACAGCACTCTGTGTTAAAGACT 801 AACTGTCTACATCTCCATATGTTGTAGTGTTGTGAAAATGTGATTTTAAAAAATTATCGCCAGTTAAAACTGGCTATTCT 881 TTTCCTCTATTTCAAAGTCATTTTTGTTCAGTGGAATAGAGACAGCAACATGGTGTTAACCTCTCAATTAAAATACAATT 961 GACACCAGTAAATTTTGCCATAAAAAGTTAAAATCTCTTGTTCAAAATATGTGTATCTTCTTAATGTGTTCATGTTAGAG 1041 AAAGTGTCCCCATCTCACTGCCAAAAATGAAAGAAAATAATTAAACTCTTTAAATGATTAAATGTAATGATTCTACTCGC 1121 AGTGCATAACAGCACATATTTTTGACAGATTATTTTTTAGGCAATTACCTTTCCTTAAGGTATCTGATACAGTATAGTAA 1201 AGAATCACTTATATCAGTAATAGCACTTGAGAGATAGCAAGTCACCAAGAAACTTAATTTTCATTTAAAATTTTATTTTG 1281 TGAATAAGGTCAATCTACAATCCCAGATAACTACATTTTTTTTCATAGATGGCCAGTGTTTTCAACAGAGATTTAAAATG 1361 GAATATTAAAATTATAGTGATTATTCAGAAGCATTTTAATTTAGAAAGGAGCTGGTTTGTTAGTTCACTGATGACATTTT 1441 TTGACAAACATTTTATACCATTATCACAATAATCAGACTTGAATTTTTTTTGGAGTTCCTTCATGTGAATGAAAACTGAG 1521 TTAAAAGAAAGTAGGCATTTAGGTCTGGATGCAGTGGCTCATGCTTGTAATCCCAGCACTTTGGGAAGCTGAAGCAGGAG 1601 GATTGCTTGAGCCCAGAAGTTCAAGACTAGCCTGGGCAACATAGTGAGACTCGGTCTCTACCAAAAAAAAAAATTTTTTT 1681 TTTTTAAATTAGCTGGGTGTGGTGGCACCTGGGAAACAGAGCGAGACGCTGACTCAAATAAATATCTAAATAGATATTTA 1761 GAATCACTGAAAACCATATTAAATGCTGGGTTAATGCTGACTTAATTGGCTTAAGGAATTTTTATAGGCGTAAGATAAAT 1841 TTTCACAGACTAAGTTTATTTCAGACAAAATAGAGAATTCTTTTAAAAGTTTTTTTTTTTTTTTTCCTTTTTCGAATGTT 1921 AATGTCTAAGACAAAGTTCAGAAAACGAGATGGCCTGTGGTAGTTTGGAAATTGCTAGATATGTTGACCGTTTCCAGGTC 2001 TTTTATCTAGTGTAGTTAAGGGAAAGCCTATTTAAGAAGTTTGGCTTCAAGTTTCTGTTTTATAAGACAAAAGTGCATAT 2081 TTCTTTACAGGCTAATGCTAGGTTTTTGTCTTTACAAATTATTTTCAGAAATGGCTAAAAGTGTACAGAAAACAGTAAAT 2161 CCCTTCTTTACTCAGAATAACTTCTTAATAGTTGAAGCATCCAAAATATGTAAAAGCAAGGGTGGGCGTAGTGGCTCTTG 2241 CCTGTAATCCCAGCATTCTGGGAGGCCGAGGCGGGCAGATCACTTGAGATCAGGAGTTCGAGACCACCCTGGCCAACGTG 2321 GTGAAACCCCGTCTCTACTAAAAATACAAAAACTAGCTGGGCATGGTGGCTTTTTTGCACGCCTATAGTCCCAGCTACTC 2401 GGGAGGCTGAGGCACGAGAATCACTTGAACCCAGGAAGTGGAGGTTGCAGTGAGCTAAGATCGTGCCACTGCACTCCAGC 2481 CTGGACAACGGAGTGAGACTCTGGGGAAAAAAAAAATTAAACTTCCTACTTTTTTTCTTTTTGTAGAGACAGAGTTTCAC 2561 TCTGTCGCCCAAGCTGGAGTGCAGTGGCACAATCATACCTCACTGCAGCCTCTTGGGCTTATGTGATCTTACCCCCTCAG 2641 CCTCTGGAGTAGCTGGAACTACAGGCTAAATTTCCTACTTTGTAAACATCAGTAGTGGCCAGATACTTCTGAGTCTTAAA 2721 AGCATAATAGGCCGGGCGCGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGAGGTGGGTGGATCACAAGGTCA 2801 GGAGTTCAAGACCAGCCTGGCCCAAATGGTGAAACCCTGTCTCTACTAAATATACAAAAATTAGCTGGGTGTGGTGGCGG 2881 GCACCTGTAATCCCAGCTACTCAGGAGGCTGAGGCAGGAGAATCGCTTGAACCTGGGAGGTGGAGGTTGTGGTGAGCCAA 2961 TATCATGCCACTGCACTCCAGCCTGGGTGACAGAGTAAGACTCCGTCTCAAAAAAAAAAAAAGCATAATAATTTATTACA 3041 TCCCAAATATATAAAAATTTGAGTGCCTTTGCAGTTGGGATGGTTCCTAAAATTGCGTATAGAATTAAGGCACAGAATTG 3121 TGTGTAAGGTCCTGAATCTGGCTAAAATACAGTGGATGTATGTATTGGAATTATGAGGCATAAGTAGCCAGTATCTATAG 3201 TTAGAATCTACAAGGCCTCCTTTTTGCACCTGTAGACTAGAATATAACTGTTATTGGTGCCTTTGAGTGTTATCTCTCAG 3281 TGGCTAGAGGTGCTGTTTCAAGCACAATTTAGACTAGGGTTGAACCACTCATTGTTCAAATCATTGGTGGGCTCCAATGT 3361 AAAATATCACTACATCAGTCCACAAGCAACATTAAGGAAATCTAAAGGAAATGGAATTTGACTTTTTAGAGTATAATGAT 3441 GTTCTAGGGCATAATGAGGAAAATTTTTAAAAAATAGATTATAATGATACATATTGGTATCATTAAGACAACAGATTTGA 3521 GCAAATACAATTAAGGTGTCTTATTTTTTGCATCAAGTAATTATTGCTGTGGTCTTTCTACTCCACAAAATAATTTTTTC 3601 TTTTTGCAGTTGAAAATTAACTGCATTATTAACTAATTAATAAAATAAATCAAGTGGTATAAGGGATTAGTTTACCCTCA 3681 AGCCGATGACTCCATGGCTACTGATATTAGTTAGTTTAGGATTTTTAAAAAGCATATCAGACCCCCAGTTTCAGGAATTG 3761 AGTATAAATATTGCTTCTTGTCACCCTGGGACAGTAATGCCTTATAGTGGCACTAGTCACCTTAAGTAGATTACACATGG 3841 TTGAGGTGAATAAAGCTGCATGGGAATTTGCTTTCGTGATATATTTCATTTGCAAACTTCTACATAATCAAGTTTTATGT 3921 TTAAAACCATCGGTTCTATATATCTAGCTTTAGGAAGTTGCCCTTACAGGTGGGACCTTTTGTGTTAATCTGTTTTCTCC 4001 CCAGTCATCTTATTTGGCTATGTTAAAAAAAAAAAAAAAAAAAAAGCGAGAGAGAGAGATGGTGTCTCACTGTGTTGCCC 4081 AGGCTGGTCTCGAACTCCTGGCCTCAAGTGACTTTCCCACCTCAGCTTCCCAAAGTGCTGGAATCACAGGCATGAGCCAC 4161 AGTGCCTGGTCTTAGCTGTGTTTTTAATTATGCCATGCATCAACATAACACCGGGCCATCTTCCTATCCCTTCCTATCCC 4241 ATATGTTTAATGAAAACATATTTTATGTGCTAAATTAGGTTAATTTACCAGAGATTTAGCTTAGTGTTTTTAAACTATAG 4321 AACAATACCCCTATAGAACAATGTACAGCTGCACCCAAGGTTAAAAAGAGGTAGCAGGGAAAACAAACTTAAACTCTTTG 4401 TATATGGTGAAACCCATCCCTCTCCTGCCCTCTAATGGTATGTTTACATTATTTCGTTATTATACAATGTAGTGGTATAA 4481 ACAGTATTATTAAACTGAAGGCATAAGTTAAAGGAAGTATGTTACTTTGAGCTGATGTAGGCTCTTCCACTTTTATCTGT 4561 ATTTTACTTATTTGGGGACTTTGTATTGCTAGGGCTTCAGAATACTAACTTTGACACAGCTCCCAGAGAGGTTTGCAAAC 4641 TTTTGGTTTCCCTCTCAAATCCATGGTAGTAGTTTCAAATGAGTTTGTGGATAATGGATGTTTAGTCCTTATCATTTGCT 4721 GTGTTTTGACAGTTTTTAATTTGCAGTATTCACTCACGAACTGTTTTATTTTAGGAATAATGCAAAACCAACCTTCGTCC 4801 GGTGATGAGAATAGCCGTATGATAAGAGAATTTGCTCATCGTGCTTTAAATGATTAACTGTTTTACCTTATTTAGTATTT 4881 CATAGACTTTGCATGATATGGTACACTCCTAATTATGCATTCTTTGGTTTCCAAATCTTAATCTAAGATACTTTGTTAAC 4961 TGACTGGTAGCCTAAGAAAGAGACTTTTCTTCCTGTTTTTCTCTCTCCCCATTTTTTGGGGTAAGTTTTGCAAAGATCAG 5041 TGCTGCTTCTCATGACTCTAAAGTAAAGCTCTTTTGGATAGCACAGCCTAACTTTACAGCTAGACAGAATGGCCATTAAG 5121 AATATTTCCAAAATCCAAGTTTATCAAAATTATTTTGTGGGAAATCATCAATCTATTTTATTAATGTTATGTGTTTAATT 5201 TTGGACTTATTTTGGGAAAAACTGTTCAAATTGGGTCCTTTTAAGCTTATTTTAAGCAGCCTAGAAGGAAGAAGCTACTT 5281 AGCTAATGAAAGCTGAGACACTTTATTAAAAGCAGGATCTTAAGAGCATTGTTTTTCCTTAAAAACTTTATACTCTCAGA 5361 TAATCTGCAACAACAAAAATTAAGAAATCCCTGACTTTTGTAGAATTCCCACTGTCAAATTCTCACTGACTTATGAGTGT 5441 GAGAGAAGTTATCTTTTGTTTGAATTCTGATAGAACAGTTTAACTCCTTTCTAAGGATATAAAAAATTCATTGGAAAGTG 5521 TGTATATTTCAAAGACTCTCAATTATCTGGACTGAAGGCACTGTTCTCACTATGGCCAGATGAATGGGAGTATTCTGTAC 5601 ATGAATCATGCTGTATTTTAAATCAGGACATCACTTAAGTATTAATGTTGTGTGTACAGATTTTTGTTTTGGGATTTTTT 5681 TTGCCTAAATAAATGTTATAAATTTTATGTAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 79699.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000294353.6 | 3UTR | CUCUACUAAAAAUACAAAAACUAGCUGGGCAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000294353.6 | 3UTR | CUACUAAAAAUACAAAAACUAGCUGGGCAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
186 hsa-miR-1303 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT035871 | SOAT1 | sterol O-acyltransferase 1 | ![]() |
1 | 1 | |||||||
MIRT035872 | FHOD3 | formin homology 2 domain containing 3 | ![]() |
1 | 1 | |||||||
MIRT035873 | RPL7A | ribosomal protein L7a | ![]() |
1 | 1 | |||||||
MIRT035874 | NCAPD2 | non-SMC condensin I complex subunit D2 | ![]() |
1 | 1 | |||||||
MIRT035875 | RPS8 | ribosomal protein S8 | ![]() |
1 | 1 | |||||||
MIRT035876 | AHNAK | AHNAK nucleoprotein | ![]() |
1 | 1 | |||||||
MIRT035877 | ACTB | actin beta | ![]() |
1 | 1 | |||||||
MIRT035878 | DEF8 | differentially expressed in FDCP 8 homolog | ![]() |
1 | 1 | |||||||
MIRT035879 | MET | MET proto-oncogene, receptor tyrosine kinase | ![]() |
1 | 1 | |||||||
MIRT035880 | MED13 | mediator complex subunit 13 | ![]() |
1 | 1 | |||||||
MIRT035881 | FAT3 | FAT atypical cadherin 3 | ![]() |
1 | 1 | |||||||
MIRT035882 | HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | ![]() |
1 | 1 | |||||||
MIRT035883 | RPS16 | ribosomal protein S16 | ![]() |
1 | 1 | |||||||
MIRT035884 | CDK6 | cyclin dependent kinase 6 | ![]() |
1 | 1 | |||||||
MIRT035885 | GEMIN5 | gem nuclear organelle associated protein 5 | ![]() |
1 | 1 | |||||||
MIRT035886 | PITRM1 | pitrilysin metallopeptidase 1 | ![]() |
1 | 1 | |||||||
MIRT035887 | PRRC2A | proline rich coiled-coil 2A | ![]() |
1 | 1 | |||||||
MIRT035888 | KIAA0226 | RUN and cysteine rich domain containing beclin 1 interacting protein | ![]() |
1 | 1 | |||||||
MIRT035889 | MLLT6 | MLLT6, PHD finger containing | ![]() |
1 | 1 | |||||||
MIRT035890 | EIF3I | eukaryotic translation initiation factor 3 subunit I | ![]() |
1 | 1 | |||||||
MIRT035891 | FASN | fatty acid synthase | ![]() |
1 | 1 | |||||||
MIRT035892 | LEPREL4 | prolyl 3-hydroxylase family member 4 (non-enzymatic) | ![]() |
1 | 1 | |||||||
MIRT035893 | HSCB | HscB mitochondrial iron-sulfur cluster cochaperone | ![]() |
1 | 1 | |||||||
MIRT035894 | PSME4 | proteasome activator subunit 4 | ![]() |
1 | 1 | |||||||
MIRT035895 | FRS2 | fibroblast growth factor receptor substrate 2 | ![]() |
1 | 1 | |||||||
MIRT035896 | ZNF264 | zinc finger protein 264 | ![]() |
1 | 1 | |||||||
MIRT035897 | HYLS1 | HYLS1, centriolar and ciliogenesis associated | ![]() |
1 | 1 | |||||||
MIRT035898 | USP54 | ubiquitin specific peptidase 54 | ![]() |
1 | 1 | |||||||
MIRT035899 | L1TD1 | LINE1 type transposase domain containing 1 | ![]() |
1 | 1 | |||||||
MIRT035900 | OR51E2 | olfactory receptor family 51 subfamily E member 2 | ![]() |
1 | 1 | |||||||
MIRT053762 | CLDN18 | claudin 18 | ![]() |
![]() |
![]() |
3 | 1 | |||||
MIRT060730 | RPS3 | ribosomal protein S3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT083986 | RAB22A | RAB22A, member RAS oncogene family | ![]() |
![]() |
2 | 2 | ||||||
MIRT098550 | TBPL1 | TATA-box binding protein like 1 | ![]() |
![]() |
2 | 6 | ||||||
MIRT134983 | TWF1 | twinfilin actin binding protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT136956 | FNDC3A | fibronectin type III domain containing 3A | ![]() |
![]() |
2 | 2 | ||||||
MIRT222065 | PURB | purine rich element binding protein B | ![]() |
![]() |
2 | 2 | ||||||
MIRT239574 | UBN2 | ubinuclein 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT261820 | BUB3 | BUB3, mitotic checkpoint protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT264698 | C11ORF57 | chromosome 11 open reading frame 57 | ![]() |
![]() |
2 | 4 | ||||||
MIRT308476 | GXYLT2 | glucoside xylosyltransferase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT377481 | NDUFB5 | NADH:ubiquinone oxidoreductase subunit B5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT442304 | NEU3 | neuraminidase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT446083 | SLC30A10 | solute carrier family 30 member 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449606 | PRPF4 | pre-mRNA processing factor 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT453767 | NUCB1 | nucleobindin 1 | ![]() |
![]() |
2 | 10 | ||||||
MIRT455603 | SRSF3 | serine and arginine rich splicing factor 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT455913 | KIF2C | kinesin family member 2C | ![]() |
![]() |
2 | 2 | ||||||
MIRT460091 | ZYG11B | zyg-11 family member B, cell cycle regulator | ![]() |
![]() |
2 | 4 | ||||||
MIRT460866 | UBE2S | ubiquitin conjugating enzyme E2 S | ![]() |
![]() |
2 | 2 | ||||||
MIRT461339 | NUP133 | nucleoporin 133 | ![]() |
![]() |
2 | 2 | ||||||
MIRT463769 | YOD1 | YOD1 deubiquitinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT466368 | THAP1 | THAP domain containing 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT467168 | SPTY2D1 | SPT2 chromatin protein domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT468703 | SDHD | succinate dehydrogenase complex subunit D | ![]() |
![]() |
2 | 2 | ||||||
MIRT469122 | RNF126 | ring finger protein 126 | ![]() |
![]() |
2 | 2 | ||||||
MIRT472426 | NCBP2 | nuclear cap binding protein subunit 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT479420 | CDKN1B | cyclin dependent kinase inhibitor 1B | ![]() |
![]() |
2 | 8 | ||||||
MIRT484260 | FAM177A1 | family with sequence similarity 177 member A1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT485468 | IL6ST | interleukin 6 signal transducer | ![]() |
![]() |
2 | 10 | ||||||
MIRT490237 | H2AFZ | H2A histone family member Z | ![]() |
![]() |
2 | 6 | ||||||
MIRT491002 | ATF7IP | activating transcription factor 7 interacting protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT492127 | SUMO2 | small ubiquitin-like modifier 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT499169 | RBPJL | recombination signal binding protein for immunoglobulin kappa J region like | ![]() |
![]() |
2 | 2 | ||||||
MIRT499825 | PCSK9 | proprotein convertase subtilisin/kexin type 9 | ![]() |
![]() |
2 | 8 | ||||||
MIRT501794 | NRAS | NRAS proto-oncogene, GTPase | ![]() |
![]() |
2 | 2 | ||||||
MIRT503441 | GINS4 | GINS complex subunit 4 | ![]() |
![]() |
2 | 4 | ||||||
MIRT503688 | MAVS | mitochondrial antiviral signaling protein | ![]() |
![]() |
2 | 5 | ||||||
MIRT506926 | IGDCC4 | immunoglobulin superfamily DCC subclass member 4 | ![]() |
![]() |
2 | 6 | ||||||
MIRT511430 | HOXA10 | homeobox A10 | ![]() |
![]() |
2 | 6 | ||||||
MIRT512415 | LAYN | layilin | ![]() |
![]() |
2 | 4 | ||||||
MIRT513791 | NIPAL3 | NIPA like domain containing 3 | ![]() |
![]() |
2 | 4 | ||||||
MIRT516163 | NTMT1 | N-terminal Xaa-Pro-Lys N-methyltransferase 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT516513 | PARK2 | parkin RBR E3 ubiquitin protein ligase | ![]() |
![]() |
2 | 2 | ||||||
MIRT516915 | HINFP | histone H4 transcription factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT517102 | NDUFV3 | NADH:ubiquinone oxidoreductase subunit V3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT517350 | NLRP9 | NLR family pyrin domain containing 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT518019 | ABHD15 | abhydrolase domain containing 15 | ![]() |
![]() |
2 | 2 | ||||||
MIRT520945 | SRSF10 | serine and arginine rich splicing factor 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT525250 | RNF213 | ring finger protein 213 | ![]() |
![]() |
2 | 2 | ||||||
MIRT530634 | PPIC | peptidylprolyl isomerase C | ![]() |
![]() |
2 | 4 | ||||||
MIRT530671 | CHRNB1 | cholinergic receptor nicotinic beta 1 subunit | ![]() |
![]() |
2 | 4 | ||||||
MIRT531563 | ILDR1 | immunoglobulin like domain containing receptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT538205 | CYR61 | cysteine rich angiogenic inducer 61 | ![]() |
![]() |
2 | 2 | ||||||
MIRT538419 | COLEC10 | collectin subfamily member 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT541964 | ZNF485 | zinc finger protein 485 | ![]() |
![]() |
2 | 2 | ||||||
MIRT543088 | KNSTRN | kinetochore localized astrin/SPAG5 binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT543257 | ZNF662 | zinc finger protein 662 | ![]() |
![]() |
2 | 2 | ||||||
MIRT543589 | KIAA1549 | KIAA1549 | ![]() |
![]() |
2 | 2 | ||||||
MIRT543955 | RNF20 | ring finger protein 20 | ![]() |
![]() |
2 | 2 | ||||||
MIRT544043 | C9orf64 | chromosome 9 open reading frame 64 | ![]() |
![]() |
2 | 4 | ||||||
MIRT548064 | GIGYF1 | GRB10 interacting GYF protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT548240 | FBXW7 | F-box and WD repeat domain containing 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT548442 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | ![]() |
![]() |
2 | 2 | ||||||
MIRT548623 | DAZAP1 | DAZ associated protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT548770 | COLEC12 | collectin subfamily member 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT549506 | HDDC2 | HD domain containing 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT551924 | AKAP8 | A-kinase anchoring protein 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT555656 | PGRMC1 | progesterone receptor membrane component 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT556286 | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT557012 | HOXD13 | homeobox D13 | ![]() |
![]() |
2 | 4 | ||||||
MIRT563907 | CLSPN | claspin | ![]() |
![]() |
2 | 2 | ||||||
MIRT565527 | SON | SON DNA binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT568000 | COMMD2 | COMM domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT569831 | PLA2G16 | phospholipase A2 group XVI | ![]() |
![]() |
2 | 4 | ||||||
MIRT573905 | PARP1 | poly(ADP-ribose) polymerase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT616589 | KLHL9 | kelch like family member 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT617137 | ZNF556 | zinc finger protein 556 | ![]() |
![]() |
2 | 2 | ||||||
MIRT617400 | API5 | apoptosis inhibitor 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT617455 | CCS | copper chaperone for superoxide dismutase | ![]() |
![]() |
2 | 2 | ||||||
MIRT617799 | ZNF793 | zinc finger protein 793 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618190 | MACC1 | MACC1, MET transcriptional regulator | ![]() |
![]() |
2 | 2 | ||||||
MIRT618303 | GNE | glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT618329 | ZNF813 | zinc finger protein 813 | ![]() |
![]() |
2 | 2 | ||||||
MIRT618820 | PHF20 | PHD finger protein 20 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619153 | PPDPF | pancreatic progenitor cell differentiation and proliferation factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT619530 | ZNF708 | zinc finger protein 708 | ![]() |
![]() |
2 | 2 | ||||||
MIRT619849 | KIR3DX1 | killer cell immunoglobulin like receptor, three Ig domains X1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT620806 | SLC26A2 | solute carrier family 26 member 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT621312 | YIPF4 | Yip1 domain family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT621358 | GUCA1B | guanylate cyclase activator 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT621366 | ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | ![]() |
![]() |
2 | 2 | ||||||
MIRT621547 | ZMYM1 | zinc finger MYM-type containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT621883 | TAOK1 | TAO kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT622451 | RNF19B | ring finger protein 19B | ![]() |
![]() |
2 | 2 | ||||||
MIRT623404 | KREMEN1 | kringle containing transmembrane protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT623587 | IPO9 | importin 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT623974 | FAM63A | MINDY lysine 48 deubiquitinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT624086 | DPP8 | dipeptidyl peptidase 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT624108 | DNAH10OS | dynein axonemal heavy chain 10 opposite strand | ![]() |
![]() |
2 | 2 | ||||||
MIRT632486 | RNF8 | ring finger protein 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634057 | PLIN3 | perilipin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT634657 | GDE1 | glycerophosphodiester phosphodiesterase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT640682 | MCUR1 | mitochondrial calcium uniporter regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT641242 | CENPN | centromere protein N | ![]() |
![]() |
2 | 2 | ||||||
MIRT642260 | ZNF677 | zinc finger protein 677 | ![]() |
![]() |
2 | 2 | ||||||
MIRT642954 | RELA | RELA proto-oncogene, NF-kB subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT644326 | IPP | intracisternal A particle-promoted polypeptide | ![]() |
![]() |
2 | 2 | ||||||
MIRT644632 | ICA1L | islet cell autoantigen 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT645721 | POLR3A | RNA polymerase III subunit A | ![]() |
![]() |
2 | 2 | ||||||
MIRT647850 | LYPLA1 | lysophospholipase I | ![]() |
![]() |
2 | 2 | ||||||
MIRT649281 | NEK8 | NIMA related kinase 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT650038 | VHL | von Hippel-Lindau tumor suppressor | ![]() |
![]() |
2 | 2 | ||||||
MIRT650354 | RRP36 | ribosomal RNA processing 36 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651144 | ZNF384 | zinc finger protein 384 | ![]() |
![]() |
2 | 2 | ||||||
MIRT651778 | UTP6 | UTP6, small subunit processome component | ![]() |
![]() |
2 | 2 | ||||||
MIRT652576 | TLCD2 | TLC domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT654621 | PTPRJ | protein tyrosine phosphatase, receptor type J | ![]() |
![]() |
2 | 2 | ||||||
MIRT656023 | MYO5A | myosin VA | ![]() |
![]() |
2 | 2 | ||||||
MIRT656105 | MSRB3 | methionine sulfoxide reductase B3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657749 | GMEB1 | glucocorticoid modulatory element binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT657924 | GATSL2 | cytosolic arginine sensor for mTORC1 subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT658848 | DUSP19 | dual specificity phosphatase 19 | ![]() |
![]() |
2 | 2 | ||||||
MIRT659100 | DENND6A | DENN domain containing 6A | ![]() |
![]() |
2 | 2 | ||||||
MIRT659153 | DCX | doublecortin | ![]() |
![]() |
2 | 2 | ||||||
MIRT660870 | ADRBK2 | G protein-coupled receptor kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT661941 | FAHD1 | fumarylacetoacetate hydrolase domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT663577 | C10orf32 | BLOC-1 related complex subunit 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT664625 | WDPCP | WD repeat containing planar cell polarity effector | ![]() |
![]() |
2 | 4 | ||||||
MIRT666562 | RHOBTB3 | Rho related BTB domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT669992 | GPR156 | G protein-coupled receptor 156 | ![]() |
![]() |
2 | 4 | ||||||
MIRT670445 | RSBN1L | round spermatid basic protein 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT670853 | IFNAR1 | interferon alpha and beta receptor subunit 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT671942 | SPPL3 | signal peptide peptidase like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT674269 | LMOD3 | leiomodin 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT674424 | MIOX | myo-inositol oxygenase | ![]() |
![]() |
2 | 4 | ||||||
MIRT674982 | ATP5G1 | ATP synthase, H+ transporting, mitochondrial Fo complex subunit C1 (subunit 9) | ![]() |
![]() |
2 | 2 | ||||||
MIRT675038 | BACE2 | beta-site APP-cleaving enzyme 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT675309 | C2orf68 | chromosome 2 open reading frame 68 | ![]() |
![]() |
2 | 2 | ||||||
MIRT675641 | TTPAL | alpha tocopherol transfer protein like | ![]() |
![]() |
2 | 2 | ||||||
MIRT688688 | CPS1 | carbamoyl-phosphate synthase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT689369 | ZNF101 | zinc finger protein 101 | ![]() |
![]() |
2 | 2 | ||||||
MIRT689605 | AKAP6 | A-kinase anchoring protein 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT691715 | LARS | leucyl-tRNA synthetase | ![]() |
![]() |
2 | 2 | ||||||
MIRT695473 | TRAT1 | T-cell receptor associated transmembrane adaptor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT695530 | MAP4K2 | mitogen-activated protein kinase kinase kinase kinase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT695878 | CACNG8 | calcium voltage-gated channel auxiliary subunit gamma 8 | ![]() |
![]() |
2 | 2 | ||||||
MIRT696586 | ORMDL2 | ORMDL sphingolipid biosynthesis regulator 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT703007 | HEATR5A | HEAT repeat containing 5A | ![]() |
![]() |
2 | 2 | ||||||
MIRT707942 | PHKA1 | phosphorylase kinase regulatory subunit alpha 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT709765 | GPR183 | G protein-coupled receptor 183 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710332 | ZNF669 | zinc finger protein 669 | ![]() |
![]() |
2 | 2 | ||||||
MIRT713249 | ZFP30 | ZFP30 zinc finger protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT716613 | RBM18 | RNA binding motif protein 18 | ![]() |
![]() |
2 | 2 | ||||||
MIRT733414 | BAG2 | BCL2 associated athanogene 2 | ![]() |
![]() |
2 | 0 | ||||||
MIRT756135 | THSD7A | thrombospondin type 1 domain containing 7A | 3 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|